NEW YORK (GenomeWeb) – Qiagen said this week that it has joined CANCER-ID, a public-private consortium aiming at establishing standard protocols and clinical validation for blood-based biomarkers in lung and breast cancer. Qiagen will contribute its expertise in creating liquid biopsy technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.